Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
NCT02606110 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-07-12
Summary
The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.
Conditions
Sponsors & Collaborators
-
Eastern Regional Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Treatment Trial Using Low Level Laser Therapy (LLLT) for Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT01006408 ·Status: COMPLETED ·Phase: NA
-
PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy
NCT05246670 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Skin Biopsies in Chemotherapy-Induced Neuropathy
NCT00956033 ·Status: COMPLETED
-
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT04560673 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients
NCT06834685 ·Status: RECRUITING ·Phase: NA
-
Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy
NCT01347723 ·Status: COMPLETED
-
MC-5A for Chemotherapy Induced Peripheral Neuropathy
NCT01261780 ·Status: COMPLETED ·Phase: PHASE2
-
Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs
NCT01208545 ·Status: UNKNOWN
-
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT01855607 ·Status: TERMINATED ·Phase: PHASE2
-
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT00952848 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Cilostazol in Prevention of Peripheral Neuropathy
NCT05298696 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer
NCT03941743 ·Status: COMPLETED ·Phase: PHASE1
-
D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain
NCT00301080 ·Status: TERMINATED ·Phase: PHASE3
-
VGAIT for Chemotherapy-induced Peripheral Neuropathy
NCT07177820 ·Status: RECRUITING ·Phase: NA
-
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain
NCT05359133 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
NCT00195013 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT05348408 ·Status: COMPLETED ·Phase: PHASE2
-
Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device
NCT07061769 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
NCT00068445 ·Status: COMPLETED ·Phase: PHASE3
-
Acupuncture for Symptoms of Nerve Damage
NCT03183037 ·Status: COMPLETED ·Phase: NA
-
Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy
NCT01611155 ·Status: COMPLETED ·Phase: NA
-
Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy
NCT03943498 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
NCT06848348 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy
NCT04468230 ·Status: TERMINATED ·Phase: PHASE2
-
Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy
NCT00041795 ·Status: COMPLETED ·Phase: PHASE2